Home

Don't See Any Communities? Join Today!

Thank you for visiting the AASLD Engage Online Community page. These online communities are an exclusive member benefit for the AASLD Special Interest Group (SIG) members. AASLD's 16 Special Interest Groups are open for all AASLD Members to join and cover nearly every aspect of Hepatology.

If you are not an AASLD Member but wish to join to gain access to these online communities, complete your Membership Application Today!

Latest Discussions

  • Profile Picture

    RE: Hcc Surveillance

    By: Hirsh Trivedi , 14 hours ago
    Posted in: AASLD Trainee Member Community

    Thanks for the shout out Elizabeth. I agree with the above consensus. The data remains sparse. It is unclear whether pretreatment F3/F4 on transient elastography represents true pretreatment advanced fibrosis or is just a result of increased necroinflammatory ...

  • Profile Picture

    RE: Hcc Surveillance

    By: Jason Pan , 3 days ago
    Posted in: AASLD Trainee Member Community

    Agree with others above. In HCV patients with pre-treatment F3-F4 fibrosis, they should continue q6month HCC surveillance. 40-60% of patients with pre-SVR F3-F4 fibrosis will show rapid improved Fibroscan scores, especially with DAA therapy. Oftentimes ...

  • Profile Picture

    RE: Hcc Surveillance

    By: Elizabeth Aby , 3 days ago
    Posted in: AASLD Trainee Member Community

    Thank you  Prashanth - this is great information! Data suggests that liver stiffness decreases after viral eradication of Hepatits C (see the recent systematic review and meta-analysis published in CGH by Singh et al attached), but regression is variable. ...

Upcoming Events